Therefore, this study explored the involvement of KLF13 in sarcopenia to elucidate the underlying molecular mechanisms and suggest novel therapeutic targets for mitigating muscle atrophy and improving the quality of life of individuals with sarcopenia. The gene discussed is KLF13; the disease is sarcopenia.